SYLENTIS Employee Directory
Biotechnology ResearchCommunity of Madrid, Spain51-200 Employees
Sylentis is a European biotechnology company focused on gene-silencing approaches to develop ophthalmology therapies. It leverages RNA interference to guide rational drug design, with the most advanced programs targeting eye diseases such as glaucoma and dry eye syndrome. The company aims to translate genetic modulation into treatments that address these conditions. Based in the Madrid region of Spain, Sylentis was founded in 2006 and is a wholly owned subsidiary of PharmaMar. In 2022, it expanded its manufacturing capabilities with a GMP compliant oligonucleotide production facility at the Madrid Technology Park in Tres Cantos. In 2024, the company appointed Andreas Segerros as Chief Executive Officer.